PRME prime Medicine announces U.S. FDA clearance of investigational new drug application for pm577a in h1069q-mutated Wilson disease
PRME prime Medicine announces U.S. FDA clearance of investigational new drug application for pm577a in h1069q-mutated Wilson disease
Story updates
08:08:44 PM UTC
SquawkNews
PRME Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease
PRME prime Medicine announces U.S.
FDA clearance of investigational new drug application for pm577a in h1069q-mutated Wilson disease